Characterizing Patient and Physician Perceptions of Systemic Lupus Erythematosus (SLE) Disease Burden Using Traditional Rheumatoid Arthritis Outcomes Measures
08:15am - 08:15am EDT - March 19, 2022
08:15am - 08:15am EDT - March 19, 2022
Author(s):
- Christopher F. Bell, GlaxoSmithKline, Research Triangle Park, NC, USA
- Shirley P. Huang, GlaxoSmithKline, Research Triangle Park, NC, USA
- Meg Wang, Analysis Group, Boston, MA, USA
- Maral DerSarkissian, Analysis Group, Boston, MA, USA
- Mei Sheng Duh, Analysis Group, Boston, MA, USA
- Bhavna Dhillon, United Rheumatology, Hauppauge, NY, USA
- Carlyne Averell, GlaxoSmithKline, Research Triangle Park, NC, USA
- Bernie Rubin, GlaxoSmithKline, Research Triangle Park, NC, USA
- Daniel Wallace, MD, Cedars-Sinai, Los Angeles, CA, USA
| Display Label | Action |
|---|---|
| RNL22P2 - Characterizing Patient and Physician Perceptions of Systemic Lupus Erythematosus (SLE) Disease Burden Using Traditional Rheumatoid Arthritis Outcomes Measures | Download MP3 |
| RNL22P2 - Characterizing Patient and Physician Perceptions of Systemic Lupus Erythematosus (SLE) Disease Burden Using Traditional Rheumatoid Arthritis Outcomes Measures | Download Handout |